Sanara MedTech

Sanara MedTech SMTI Stock

$32.73   -0.091571%
Add to favorites
Market Cap
$300.55M
LOW - HIGH [24H]
$32.33 - $32.83
VOLUME [24H]
$91.11K
P/E Ratio
0
Earnings per share
-$0.28
ISIN
US79957L1008
Price   Prediction

Sanara MedTech Price Chart

Sorry, that's all we've gotfor now...

Sanara MedTech (SMTI) stock price today is 32.73 USD on Tech Market Small (-0.09% on the day). Updated .

Sanara MedTech SMTI Financial and Trading Overview

Sanara MedTech stock price 32.73 USD
Previous Close 32.35 USD
Open 32.33 USD
Bid 23.4 USD x 200
Ask 42.07 USD x 200
Day's Range 31.78 - 32.84 USD
52 Week Range 16.05 - 35.52 USD
Volume 104.26K USD
Avg. Volume 187.73K USD
Market Cap 300.83M USD
Beta (5Y Monthly) 1.201
PE Ratio (TTM) N/A
EPS (TTM) -0.28 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 35 USD

SMTI Valuation Measures

Enterprise Value 332.82M USD
Trailing P/E N/A
Forward P/E 60.66666
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 2.6881058
Price/Book (mrq) 39.233532
Enterprise Value/Revenue 2.974
Enterprise Value/EBITDA 31.57

Trading Information

Sanara MedTech Stock Price History

Beta (5Y Monthly) 1.201
52-Week Change 53.53%
S&P500 52-Week Change 13.32%
52 Week High 35.52 USD
52 Week Low 16.05 USD
50-Day Moving Average 33.98 USD
200-Day Moving Average 25.98 USD

SMTI Share Statistics

Avg. Volume (3 month) 187.73K USD
Avg. Daily Volume (10-Days) 61.25K USD
Shares Outstanding 9.18M
Float 3.76M
Short Ratio 2.43
% Held by Insiders 49.54%
% Held by Institutions 25.34%
Shares Short 412.34K
Short % of Float 7.72%
Short % of Shares Outstanding 4.48%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:100

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -2.69%
Operating Margin (ttm) 7.19%
Gross Margin 92.95%
EBITDA Margin 9.41%

Management Effectiveness

Return on Assets (ttm) 7.02%
Return on Equity (ttm) -34.88%

Income Statement

Revenue (ttm) 111.91M USD
Revenue Per Share (ttm) 12.82 USD
Quarterly Revenue Growth (yoy) 8.00%
Gross Profit (ttm) 104.03M USD
EBITDA 10.54M USD
Net Income Avi to Common (ttm) -2407509 USD
Diluted EPS (ttm) -0.28
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 16.79M USD
Total Cash Per Share (mrq) 1.83 USD
Total Debt (mrq) 48.69M USD
Total Debt/Equity (mrq) 635.13 USD
Current Ratio (mrq) 2.236
Book Value Per Share (mrq) 0.835

Cash Flow Statement

Operating Cash Flow (ttm) 7.42M USD
Levered Free Cash Flow (ttm) 3.63M USD

Profile of Sanara MedTech

Country United States
State TX
City Fort Worth
Address 1200 Summit Avenue
ZIP 76102
Phone 817 529 2300
Website https://sanaramedtech.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 108

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial and full-thickness wounds, as well as first and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY Tissue Repair Graft(FORTIFY TRG), a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; BiFORM, an osteoconductive, bioactive, porous implant that allows bony ingrowth across the graft site and it can be used as a strip or molded into a putty to fill a bone defect; ACTIGEN Inductive Bone Matrix, a naturally derived, differentiated allograft matrix with robust handling properties; ALLOCYTE Plus, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers; and TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement. The company has a license agreement with Rochal to develop, market, and sell antimicrobial products that include BIASURGE Advanced Surgical Solution, BIAKOS Antimicrobial Wound Gel, and BIAKOS Antimicrobial Skin and Wound Cleanser for the prevention and treatment of microbes on the human body. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

Q&A For Sanara MedTech Stock

What is a current SMTI stock price?

Sanara MedTech SMTI stock price today per share is 32.73 USD.

How to purchase Sanara MedTech stock?

You can buy SMTI shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Sanara MedTech?

The stock symbol or ticker of Sanara MedTech is SMTI.

Which industry does the Sanara MedTech company belong to?

The Sanara MedTech industry is Medical Instruments & Supplies.

How many shares does Sanara MedTech have in circulation?

The max supply of Sanara MedTech shares is 9.18M.

What is Sanara MedTech Price to Earnings Ratio (PE Ratio)?

Sanara MedTech PE Ratio is now.

What was Sanara MedTech earnings per share over the trailing 12 months (TTM)?

Sanara MedTech EPS is -0.28 USD over the trailing 12 months.

Which sector does the Sanara MedTech company belong to?

The Sanara MedTech sector is Healthcare.

Sanara MedTech SMTI included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24328.38 USD —
-0.74
8.59B USD — 23989.09 USD — 24547.66 USD — — 8.59B USD —
us US Tech Health Care IXHC US 1332.89 USD —
-0.73
— — 1323.81 USD — 1342.94 USD — — — —
$2.18T
Total marketcap
$72.01B
Total volume
BTC 59.04%   •   ETH 10.04%
Dominance
Select currency